On January 25, 2019, Rich Sampson was quoted in the Boston Business Journal article “Supreme Court ruling raises concerns about pharmaceutical, tech patents” by Alison DeAngelis. Rich provided his perspective on the impact of a recent Supreme Court decision in Helsinn Healthcare v. Teva Pharmaceuticals. Read the article in the Boston Business Journal (subscription required).

Return to Resources